Glioblastoma multiforme: a glance at advanced therapies based on nanotechnology

References

• Phillips KA, Fadul CE, Schiff D. Neurologic and medical management of brain tumors. Neurol Clin. 2018;36:449–466.
   PubMed Web of Science ®Google Scholar
• Komori T. The 2016 WHO Classification of tumours of the central nervous system: The major points of revision. Neurol Med Chir (Tokyo). 2017;57:301–311.
   PubMed Web of Science ®Google Scholar
• Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, Il'yasova D, et al, On behalf of the Brain Tumor Epidemiology Consortium. Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer. 2008;113:1953–1968.
   PubMed Web of Science ®Google Scholar
• Rajesh Y, Pal I, Banik P, Chakraborty S, Borkar SA, Dey G, et al. Insights into molecular therapy of glioma: current challenges and next generation blueprint. Acta Pharmacol Sin. 2017;38:591–613.
   PubMed Web of Science ®Google Scholar
• Clarke J, Butowski N, Chang S. Recent advances in therapy for glioblastoma. Arch Neurol. 2010;67:279–283.
   PubMedGoogle Scholar
• Glaser T, Han I, Wu L, Zeng X. Targeted nanotechnology in glioblastoma multiforme. Front Pharmacol. 2017;8:166.
   PubMed Web of Science ®Google Scholar
• Baklaushev VP, Nukolova NN, Khalansky AS, Gurina OI, Yusubalieva GM, Grinenko NP, et al. Treatment of glioma by cisplatin-loaded nanogels conjugated with monoclonal antibodies against Cx43 and BSAT1. Drug Del. 2015;22:276–285.
   PubMed Web of Science ®Google Scholar
• Zhou M, Zhang Z, Zhao H, Bao S, Cheng L, Sun J. An immune-related six-lncRNA signature to improve prognosis prediction of glioblastoma multiforme. Mol Neurobiol. 2018;55:3684–3697.
   PubMed Web of Science ®Google Scholar
• Ferronato MJ, Alonso EN, Salomon DG, Fermento ME, Gandini NA, Quevedo MA, et al. Antitumoral effects of the alkynylphosphonate analogue of calcitriol EM1 on glioblastoma multiforme cells. J Steroid Biochem Mol Biol. 2018;178:22–35.
   PubMed Web of Science ®Google Scholar
• Ostrom QT, Cote DJ, Ascha M, Kruchko C, Barnholtz-Sloan JS. Adult glioma incidence and survival by race or ethnicity in the United States from 2000 to 2014. JAMA Oncol. 2018;4:1254–1262.
   PubMed Web of Science ®Google Scholar
• Thakkar JP, Dolecek TA, Horbinski C, Ostrom QT, Lightner DD, Barnholtz-Sloan JS, et al. Epidemiologic and molecular prognostic review of glioblastoma. Cancer Epidemiol Biomarkers Prev. 2014;23:1985–1996.
   PubMed Web of Science ®Google Scholar
• Hanif F, Muzaffar K, Perveen K, Malhi SM, Simjee Sh U. Glioblastoma multiforme: A review of its epidemiology and pathogenesis through clinical presentation and treatment. Asian Pacific J Cancer Prev. 2017;18:3–9.
   PubMedGoogle Scholar
• Franco T, Roque C, Khorasanizadeh S, McCullough LD. A 25-year-old man with progressive left-sided weakness and a mass lesion on brain imaging. J Postgrad Med. 2009;55:214–219.
   PubMed Web of Science ®Google Scholar
• Nam L, Coll C, Erthal LCS, de la Torre C, Serrano D, Martinez-Manez R, et al. Drug delivery nanosystems for the localized treatment of glioblastoma multiforme. Mater (Basel, Switzerland). 2018;11(5):779.
   Web of Science ®Google Scholar
• Bansal K, Liang ML, Rutka JT. Molecular biology of human gliomas. Technol Cancer Res Treat. 2006;5:185–194.
   PubMed Web of Science ®Google Scholar
• Myong NH, Park BJ. Malignant glioma arising at the site of an excised cerebellar hemangioblastoma after irradiation in a von Hippel-Lindau disease patient. Yonsei Med J. 2009;50:576–581.
   PubMed Web of Science ®Google Scholar
• Davis ME. Glioblastoma: Overview of disease and treatment. Clin J Oncol Nursing. 2016;20:S2–S8.
   PubMed Web of Science ®Google Scholar
• Little RB, Madden MH, Thompson RC, Olson JJ, Larocca RV, Pan E, et al. Anthropometric factors in relation to risk of glioma. Cancer Causes Control. 2013;24:1025–1031.
   PubMed Web of Science ®Google Scholar
• Bradshaw A, Wickremsekera A, Tan ST, Peng L, Davis PF, Itinteang T. Cancer stem cell hierarchy in glioblastoma multiforme. Front Surg. 2016;3:21.
   PubMed Web of Science ®Google Scholar
• Jawhari S, Ratinaud MH, Verdier M. Glioblastoma, hypoxia and autophagy: a survival-prone 'menage-a-trois. Cell Death Dis. 2016;7:e2434.
   PubMed Web of Science ®Google Scholar
• Yi Y, Hsieh IY, Huang X, Li J, Zhao W. Glioblastoma stem-like cells: Characteristics, microenvironment, and therapy. Front Pharmacol. 2016;7:477.
   PubMed Web of Science ®Google Scholar
• Ramachandran R, Junnuthula VR, Gowd GS, Ashokan A, Thomas J, Peethambaran R, et al. Theranostic 3-Dimensional nano brain-implant for prolonged and localized treatment of recurrent glioma. Sci Rep. 2017;7:43271.
   PubMed Web of Science ®Google Scholar
• Pearson JRD, Regad T. Targeting cellular pathways in glioblastoma multiforme. Sig Transduct Target Ther. 2017;2:17040.
   PubMed Web of Science ®Google Scholar
• Tseng YY, Huang YC, Yang TC, Yang ST, Liu SC, Chang TM, et al. Concurrent chemotherapy of malignant glioma in rats by using multidrug-loaded biodegradable nanofibrous membranes. Sci Rep. 2016;6:30630.
   PubMed Web of Science ®Google Scholar
• Kane JR, Miska J, Young JS, Kanojia D, Kim JW, Lesniak MS. Sui generis: gene therapy and delivery systems for the treatment of glioblastoma. Neuro-Oncol. 2015;17:ii24–ii36.
   PubMed Web of Science ®Google Scholar
• Kwiatkowska A, Nandhu MS, Behera P, Chiocca EA, Viapiano MS. Strategies in gene therapy for glioblastoma. Cancers. 2013;5:1271–1305.
   PubMedGoogle Scholar
• Caffery B, Lee JS, Alexander-Bryant AA. Vectors for glioblastoma gene therapy: Viral & non-viral delivery strategies. Nanomater (Basel, Switzerland). 2019;9:105.
   Google Scholar
• Gutkin A, Cohen ZR, Peer D. Harnessing nanomedicine for therapeutic intervention in glioblastoma. Expert Opin Drug Del. 2016;13:1573–1582.
   PubMed Web of Science ®Google Scholar
• Qian L, Zheng J, Wang K, Tang Y, Zhang X, Zhang H, et al. Cationic core-shell nanoparticles with Carmustine contained within O(6)-benzylguanine shell for glioma therapy. Biomater. 2013;34:8968–8978.
   PubMed Web of Science ®Google Scholar
• Lim WM, Rajinikanth PS, Mallikarjun C, Kang YB. Formulation and delivery of itraconazole to the brain using a nanolipid carrier system. Int J Nanomedicine. 2014;9:2117–2126.
   PubMed Web of Science ®Google Scholar
• Setua S, Ouberai M, Piccirillo SG, Watts C, Welland M. Cisplatin-tethered gold nanospheres for multimodal chemo-radiotherapy of glioblastoma. Nanoscale. 2014;6:10865–10873.
   PubMed Web of Science ®Google Scholar
• Ebrahimi Shahmabadi H, Movahedi F, Koohi Moftakhari Esfahani M, Alavi SE, Eslamifar A, Mohammadi Anaraki G, et al. Efficacy of Cisplatin-loaded polybutyl cyanoacrylate nanoparticles on the glioblastoma. Tumor Biol. 2014;35:4799–4806.
   PubMed Web of Science ®Google Scholar
• Nance E, Zhang C, Shih TY, Xu Q, Schuster BS, Hanes J. Brain-penetrating nanoparticles improve paclitaxel efficacy in malignant glioma following local administration. ACS Nano. 2014;8:10655–10664.
   PubMed Web of Science ®Google Scholar
• Wang B, Lv L, Wang Z, Jiang Y, Lv W, Liu X, et al. Improved anti-glioblastoma efficacy by IL-13Ralpha2 mediated copolymer nanoparticles loaded with paclitaxel. Sci Rep. 2015;5:16589.
   PubMed Web of Science ®Google Scholar
• Wu M, Fan Y, Lv S, Xiao B, Ye M, Zhu X. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery. Drug Del. 2016;23:2720–2725.
   PubMed Web of Science ®Google Scholar
• Kuo Y-C, Lee I-H. Delivery of doxorubicin to glioblastoma multiforme in vitro using solid lipid nanoparticles with surface aprotinin and melanotransferrin antibody for enhanced chemotherapy. J Taiwan Institute Chem Eng. 2016;61:32–45.
   Web of Science ®Google Scholar
• Fisusi FA, Siew A, Chooi KW, Okubanjo O, Garrett N, Lalatsa K, et al. Lomustine nanoparticles enable both bone marrow sparing and high brain drug levels - A strategy for brain cancer treatments. Pharm Res. 2016;33:1289–1303.
   PubMed Web of Science ®Google Scholar
• Mu Q, Jeon M, Hsiao MH, Patton VK, Wang K, Press OW, et al. Stable and efficient Paclitaxel nanoparticles for targeted glioblastoma therapy. Adv Healthcare Mater. 2015;4:1236–1245.
   Web of Science ®Google Scholar
• Shaw TK, Mandal D, Dey G, Pal MM, Paul P, Chakraborty S, et al. Successful delivery of docetaxel to rat brain using experimentally developed nanoliposome: a treatment strategy for brain tumor. Drug Del. 2017;24:346–357.
   PubMed Web of Science ®Google Scholar
• Gao X, Yu T, Xu G, Guo G, Liu X, Hu X, et al. Enhancing the anti-glioma therapy of doxorubicin by honokiol with biodegradable self-assembling micelles through multiple evaluations. Sci Rep. 2017;7:43501.
   PubMed Web of Science ®Google Scholar
• Maleki H, Dorkoosh F, Adabi M, Khosravani M, Arzani H, Kamali M. Methotrexate-loaded PLGA nanoparticles: Preparation, characterization and their cytotoxicity effect on human glioblastoma U87MG cells. Int J Med Nano Res. 2017;4:20.
   Google Scholar
• Battaglia L, Muntoni E, Chirio D, Peira E, Annovazzi L, Schiffer D, et al. Solid lipid nanoparticles by coacervation loaded with a methotrexate prodrug: preliminary study for glioma treatment. Nanomed (London, England). 2017;12:639–656.
   PubMed Web of Science ®Google Scholar
• Wang Y, Ying X, Xu H, Yan H, Li X, Tang H. The functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals. Int J Nanomed. 2017;12:1369–1384.
   PubMed Web of Science ®Google Scholar
• Irani M, Sadeghi GMM, Haririan I. The sustained delivery of temozolomide from electrospun PCL-Diol-b-PU/gold nanocompsite nanofibers to treat glioblastoma tumors. Mater Sci Eng C, Mater Biol Appl. 2017;75:165–174.
   PubMed Web of Science ®Google Scholar
• Hua H, Zhang X, Mu H, Meng Q, Jiang Y, Wang Y, et al. RVG29-modified docetaxel-loaded nanoparticles for brain-targeted glioma therapy. Int J Pharmac. 2018;543:179–189.
   PubMed Web of Science ®Google Scholar
• Coluccia D, Figueiredo CA, Wu MY, Riemenschneider AN, Diaz R, Luck A, et al. Enhancing glioblastoma treatment using cisplatin-gold-nanoparticle conjugates and targeted delivery with magnetic resonance-guided focused ultrasound. Nanomed: Nanotechnol, Biol Med. 2018;14:1137–1148.
   PubMed Web of Science ®Google Scholar
• Madala HR, Punganuru SR, Ali-Osman F, Zhang R, Srivenugopal KS. Brain- and brain tumor-penetrating disulfiram nanoparticles: Sequence of cytotoxic events and efficacy in human glioma cell lines and intracranial xenografts. Oncotarget. 2018;9:3459–3482.
   PubMedGoogle Scholar
• Shirvalilou S, Khoei S, Khoee S, Raoufi NJ, Karimi MR, Shakeri-Zadeh A. Development of a magnetic nano-graphene oxide carrier for improved glioma-targeted drug delivery and imaging: In vitro and in vivo evaluations. Chemico-Biol Interact. 2018;295:97–108.
   PubMed Web of Science ®Google Scholar
• Li X, Tsibouklis J, Weng T, Zhang B, Yin G, Feng G, et al. Nano carriers for drug transport across the blood-brain barrier. J Drug Target. 2017;25:17–28.
   PubMed Web of Science ®Google Scholar
• Zhao J, Zhang B, Shen S, Chen J, Zhang Q, Jiang X, et al. CREKA peptide-conjugated dendrimer nanoparticles for glioblastoma multiforme delivery. J Colloid Interface Sci. 2015;450:396–403.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Lv L, Shi H, Hua Y, Lv W, Wang X, et al. PEGylated Polyamidoamine dendrimer conjugated with tumor homing peptide as a potential targeted delivery system for glioma. Colloids Surf B, Biointerf. 2016;147:242–249.
   PubMed Web of Science ®Google Scholar
• Singh I, Swami R, Pooja D, Jeengar MK, Khan W, Sistla R. Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting. J Drug Target. 2016;24:212–223.
   PubMed Web of Science ®Google Scholar
• rosina G. Nanoparticle-mediated drug delivery to high-grade gliomas. Nanomed: Nanotechnol, Biol Med. 2016;12:1083–1093.
   PubMed Web of Science ®Google Scholar
• Borran AA, Aghanejad A, Farajollahi A, Barar J, Omidi Y. Gold nanoparticles for radiosensitizing and imaging of cancer cells. Radiat Phys Chem. 2018;152:137–144.
   Web of Science ®Google Scholar
• Thakor AS, Jokerst J, Zavaleta C, Massoud TF, Gambhir SS. Gold nanoparticles: a revival in precious metal administration to patients. Nano Lett. 2011;11:4029–4036.
   PubMed Web of Science ®Google Scholar
• Dimitriou NM, Tsekenis G, Balanikas EC, Pavlopoulou A, Mitsiogianni M, Mantso T, et al. Gold nanoparticles, radiations and the immune system: Current insights into the physical mechanisms and the biological interactions of this new alliance towards cancer therapy. Pharmacol Therapeutics. 2017;178:1–17.
   PubMed Web of Science ®Google Scholar
• Meola A, Rao J, Chaudhary N, Sharma M, Chang SD. Gold nanoparticles for brain tumor imaging: A systematic review. Front Neurol. 2018;9:328.
   PubMed Web of Science ®Google Scholar
• Kunz-Schughart LA, Dubrovska A, Peitzsch C, Ewe A, Aigner A, Schellenburg S, et al. Nanoparticles for radiooncology: Mission, vision, challenges. Biomaterials. 2017;120:155–184.
   PubMed Web of Science ®Google Scholar
• Mokhtarzadeh A, Hassanpour S, Vahid ZF, Hejazi M, Hashemi M, Ranjbari J, et al. Nano-delivery system targeting to cancer stem cell cluster of differentiation biomarkers. J Control Release. 2017;266:166–186.
   PubMed Web of Science ®Google Scholar
• Bahrami B, Hojjat-Farsangi M, Mohammadi H, Anvari E, Ghalamfarsa G, Yousefi M, et al. Nanoparticles and targeted drug delivery in cancer therapy. Immunol Lett. 2017;190:64–83.
   PubMed Web of Science ®Google Scholar
• Shevtsov MA, Nikolaev BP, Yakovleva LY, Marchenko YY, Dobrodumov AV, Mikhrina AL, et al. Superparamagnetic iron oxide nanoparticles conjugated with epidermal growth factor (SPION-EGF) for targeting brain tumors. Int J Nanomedicine. 2014;9:273–287.
   PubMed Web of Science ®Google Scholar
• Reszka RC, Jacobs A, Voges J. Liposome-mediated suicide gene therapy in humans. Meth Enzymol. 2005;391:200–208.
   PubMed Web of Science ®Google Scholar
• Cai X, Sughrue ME. Glioblastoma: new therapeutic strategies to address cellular and genomic complexity. Oncotarget. 2018;9:9540–9554.
   PubMedGoogle Scholar
• Aldape K, Zadeh G, Mansouri S, Reifenberger G, von Deimling A. Glioblastoma: pathology, molecular mechanisms and markers. Acta Neuropathol. 2015;129:829–848.
   PubMed Web of Science ®Google Scholar
• Kim SS, Rait A, Kim E, Pirollo KF, Nishida M, Farkas N, et al. A nanoparticle carrying the p53 gene targets tumors including cancer stem cells, sensitizes glioblastoma to chemotherapy and improves survival. ACS Nano. 2014;8:5494–5514.
   PubMed Web of Science ®Google Scholar
• Choi E, Han J, Tan X, Oh J, Lee D, Rhim T, et al. Combined delivery of temozolomide and the thymidine kinase gene for treatment of glioblastoma. J Drug Targeting. 2017;25:156–162.
   PubMed Web of Science ®Google Scholar
• Li AJ, Zheng YH, Liu GD, Liu WS, Cao PC, Bu ZF. Efficient delivery of docetaxel for the treatment of brain tumors by cyclic RGD-tagged polymeric micelles. Mol Med Rep. 2015;11:3078–3086.
   PubMed Web of Science ®Google Scholar
• Tan X, Kim G, Lee D, Oh J, Kim M, Piao C, et al. A curcumin-loaded polymeric micelle as a carrier of a microRNA-21 antisense-oligonucleotide for enhanced anti-tumor effects in a glioblastoma animal model. Biomater Sci. 2018;6:407–417.
   PubMed Web of Science ®Google Scholar
• Jiao X, Yu Y, Meng J, He M, Zhang CJ, Geng W, et al. Dual-targeting and microenvironment-responsive micelles as a gene delivery system to improve the sensitivity of glioma to radiotherapy. Acta Pharmaceut Sin B. 2019;9:381–396.
   PubMed Web of Science ®Google Scholar
• Yoshida J, Mizuno M, Fujii M, Kajita Y, Nakahara N, Hatano M, et al. Human gene therapy for malignant gliomas (glioblastoma multiforme and anaplastic astrocytoma) by in vivo transduction with human interferon beta gene using cationic liposomes. Human Gene Ther. 2004;15:77–86.
   PubMed Web of Science ®Google Scholar
• Sun X, Pang Z, Ye H, Qiu B, Guo L, Li J, et al. Co-delivery of pEGFP-hTRAIL and paclitaxel to brain glioma mediated by an angiopep-conjugated liposome. Biomaterials. 2012;33:916–924.
   PubMed Web of Science ®Google Scholar
• Ito A, Shinkai M, Honda H, Kobayashi T. Heat-inducible TNF-alpha gene therapy combined with hyperthermia using magnetic nanoparticles as a novel tumor-targeted therapy. Cancer Gene Ther. 2001;8:649–654.
   PubMed Web of Science ®Google Scholar
• Kato T, Natsume A, Toda H, Iwamizu H, Sugita T, Hachisu R, et al. Efficient delivery of liposome-mediated MGMT-siRNA reinforces the cytotoxity of temozolomide in GBM-initiating cells. Gene Ther. 2010;17:1363–1371.
   PubMed Web of Science ®Google Scholar
• Costa PM, Cardoso AL, Custodia C, Cunha P, Pereira de Almeida L, Pedroso de Lima MC. MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma. J Control Release. 2015;207:31–39.
   PubMed Web of Science ®Google Scholar
• Bai CZ, Choi S, Nam K, An S, Park JS. Arginine modified PAMAM dendrimer for interferon beta gene delivery to malignant glioma. Int J Pharmaceut. 2013;445:79–87.
   PubMed Web of Science ®Google Scholar
• Han L, Zhang A, Wang H, Pu P, Jiang X, Kang C, et al. Tat-BMPs-PAMAM conjugates enhance therapeutic effect of small interference RNA on U251 glioma cells in vitro and in vivo. Human Gene Therapy. 2010;21:417–426.
   PubMed Web of Science ®Google Scholar
• Bae Y, Thuy LT, Lee YH, Ko KS, Han J, Choi JS. Polyplexes of functional PAMAM dendrimer/apoptin gene induce apoptosis of human primary glioma cells in vitro. Polymers. 2019;11:296.
   Web of Science ®Google Scholar
• Kang C, Yuan X, Li F, Pu P, Yu S, Shen C, et al. Evaluation of folate-PAMAM for the delivery of antisense oligonucleotides to rat C6 glioma cells in vitro and in vivo. J Biomed Mater Res. 2010;93:585–594.
   Google Scholar
• Gao S, Li J, Jiang C, Hong B, Hao B. Plasmid pORF-hTRAIL targeting to glioma using transferrin-modified polyamidoamine dendrimer. Drug Des Devel Ther. 2016;10:1–11.
   PubMed Web of Science ®Google Scholar
• Grabowska M, Grześkowiak BF, Szutkowski K, Wawrzyniak D, Głodowicz P, Barciszewski J, et al. Nano-mediated delivery of double-stranded RNA for gene therapy of glioblastoma multiforme. PLoS One. 2019;14:e0213852.
   PubMed Web of Science ®Google Scholar
• Kievit FM, Veiseh O, Fang C, Bhattarai N, Lee D, Ellenbogen RG, et al. Chlorotoxin labeled magnetic nanovectors for targeted gene delivery to glioma. ACS Nano. 2010;4:4587–4594.
   PubMed Web of Science ®Google Scholar
• Long L, Wang W, Cai XD, Cheng D, Shuai X, Peng Y. PinX1-siRNA/mPEG-PEI-SPION combined with doxorubicin enhances the inhibition of glioma growth. Exper Therap Med. 2014;7:1170–1176.
   PubMed Web of Science ®Google Scholar
• Mahmoudi K, Bouras A, Bozec D, Ivkov R, Hadjipanayis C. Magnetic hyperthermia therapy for the treatment of glioblastoma: a review of the therapy's history, efficacy and application in humans. Int J Hyperthermia. 2018;34:1316–1328.
   PubMed Web of Science ®Google Scholar
• Pinel S, Thomas N, Boura C, Barberi-Heyob M. Approaches to physical stimulation of metallic nanoparticles for glioblastoma treatment. Adv Drug Del Rev. 2019;138:344–357.
   PubMed Web of Science ®Google Scholar
• Wankhede M, Bouras A, Kaluzova M, Hadjipanayis CG. Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy. Expert Rev Clin Pharmacol. 2012;5:173–186.
   PubMed Web of Science ®Google Scholar
• Gupta R, Sharma D. Evolution of magnetic hyperthermia for glioblastoma multiforme therapy. ACS Chem Neurosci. 2019;10:1157–1172.
   PubMed Web of Science ®Google Scholar
• Sun L, Joh DY, Al-Zaki A, Stangl M, Murty S, Davis JJ, et al. Theranostic application of mixed gold and superparamagnetic iron oxide nanoparticle micelles in glioblastoma multiforme. J Biomed Nanotechnol. 2016;12:347–356.
   PubMed Web of Science ®Google Scholar
• Meir R, Betzer O, Motiei M, Kronfeld N, Brodie C, Popovtzer R. Design principles for noninvasive, longitudinal and quantitative cell tracking with nanoparticle-based CT imaging. Nanomed: Nanotechnol Biol Med. 2017;13:421–429.
   PubMed Web of Science ®Google Scholar